15/05/2022
Well well well, it's Edition 006 of The Hilltop Pharma Herald!
We’ll be routinely releasing our newspaper highlighting company news and important / interesting stories in the industry via Twitter, Facebook and on LinkedIn.
We're happy to do our part with the to make news easy and digestible!
Sources for this week's article on RPi - Acting in Great Britain as a Responsible Person in relation to imports :
1. “Countries in the EU and EEA” | GOV.UK
| https://www.gov.uk/eu-eea
2. “Guidance: Acting as a Responsible Person (import)” | GOV.UK
| https://lnkd.in/dbxSsfKF
3. “Good Distribution Practice (GDP) requirements” | The Official Journal of the European Union | https://lnkd.in/e-C8yDRi
4. “REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU” | The Official Journal of the European Union | https://lnkd.in/ecKtfWgV
5. “Human OCABR Guidelines” | European Directorate for the
Quality of Medicines & HealthCare | https://lnkd.in/dRrcf_s
6. “Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use Text with EEA relevance” | The Official Journal of the European Union | https://lnkd.in/ehn2YgFH
7. “The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019” | Legislation.gov.uk
| https://lnkd.in/ecWGUf5s
It's easy to keep up with Hilltop across the internet!
Twitter: https://lnkd.in/gQwPZRaQ
LinkedIn: https://www.linkedin.com/company/77048522/
And of course you can always learn more about our services, core ethos and more on our official website:
https://lnkd.in/gwg6mTMt